Dioon rzedowskii: An antioxidant, antibacterial and anticancer plant extract with multi-faceted effects on cell growth and molecular signaling.

Antibacterial activity Dioon rzedowskii MAPK pathway Solid Ehrlich carcinoma Toxicity profile

Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
29 Mar 2024
Historique:
received: 17 01 2024
revised: 18 03 2024
accepted: 26 03 2024
medline: 31 3 2024
pubmed: 31 3 2024
entrez: 30 3 2024
Statut: aheadofprint

Résumé

This study investigated the antioxidant, anticancer, antibacterial properties of Dioon rzedowskii extract, which had not been previously explored. We aimed to determine the extract's effect on liver and breast cancer cell lines and on solid Ehrlich carcinoma (SEC) mouse model to investigate the underlying molecular mechanisms. Three female albino mice groups were established: a tumor control group, a group treated with 100 mg/kg of the extract (D100), and a group treated with 200 mg/kg of the extract (D200) for 16 days after tumor development. Results showed that the D. rzedowskii extract inhibited cell growth in both MCF-7 and HepG2 cells in a concentration-dependent manner. This was achieved by suppressing the cell proliferation and inducing apoptosis. The extract also improved liver, heart, and kidney functions compared to the tumor control. Furthermore, oral administration of the extract reduced tumor volume and alleviated oxidative stress in tumor tissue. The anticancer effects were associated with overexpression of p53 and Bax and downregulation of cyclin D1 expression, which was attributed to decreased phosphorylated MAPK kinases. Additionally, D. rzedowskii exhibited antibacterial activity against K. pneumoniae isolated from cancer patients. The extract inhibited bacterial growth and reduced the membrane integrity. The study suggests that D. rzedowskii has promising potential as an adjunctive therapy for cancer treatment. Further investigations are needed to explore its combined anticancer efficacy. These results emphasize the value of natural products in developing compounds with potential anticancer activity and support a paradigm shift in cancer management to improve patients' quality of life.

Identifiants

pubmed: 38554441
pii: S1567-5769(24)00475-2
doi: 10.1016/j.intimp.2024.111957
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111957

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Walaa A Negm (WA)

Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt. Electronic address: walaa.negm@pharm.tanta.edu.eg.

Engy Elekhnawy (E)

Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt. Electronic address: engy.ali@pharm.tanta.edu.eg.

Sebaey Mahgoub (S)

Food Analysis Laboratory, Ministry of Health, Zagazig, Egypt.

Hanaa A Ibrahim (HA)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt. Electronic address: hanaa.abdelkareem@pharm.tanta.edu.eg.

Aya Ibrahim Elberri (A)

Genetic Engineering and Molecular Biology Division, Department of Zoology, Faculty of Science, Menoufia University, 32511 Shebin El-Kom, Menoufia, Egypt. Electronic address: ayaelbery62@science.menofia.edu.eg.

Hend E Abo Mansour (HE)

Biochemistry Department, Faculty of Pharmacy, Menoufia University, 32511 Shebin EL-Kom, Menoufia, Egypt. Electronic address: hend_elsaid@phrm.menofia.edu.eg.

Esraa M Mosalam (EM)

Biochemistry Department, Faculty of Pharmacy, Menoufia University, 32511 Shebin EL-Kom, Menoufia, Egypt; Department of Pharmacy, Faculty of Pharmacy, Jadara University, Irbid, Jordan. Electronic address: esraa.mosalam@phrm.menofia.edu.eg.

Ehssan Moglad (E)

Department of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia. Electronic address: e.moglad@psau.edu.sa.

Fatma Alzahraa Mokhtar (F)

Department of Pharmacognosy, Faculty of Pharmacy, El Saleheya El Gadida University, El Saleheya El Gadida 44813, Sharkia, Egypt; Fujairah Research Centre, Sakamkam Road, Fujairah, United Arab Emirates.

Classifications MeSH